2-(1-octynyl)adenosine has been researched along with Glaucoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Donegan, RK; Lieberman, RL | 1 |
| Kogi, K; Konno, T; Murakami, A; Nagai, A; Nakahata, N; Uchibori, T | 1 |
1 review(s) available for 2-(1-octynyl)adenosine and Glaucoma
| Article | Year |
|---|---|
Discovery of Molecular Therapeutics for Glaucoma: Challenges, Successes, and Promising Directions.
Topics: Adrenergic Agonists; Adrenergic Antagonists; Adrenergic beta-Antagonists; Animals; Drug Discovery; Glaucoma; Humans; Ligands; Protein Kinase Inhibitors; rho-Associated Kinases; Sympathomimetics | 2016 |
1 other study(ies) available for 2-(1-octynyl)adenosine and Glaucoma
| Article | Year |
|---|---|
Involvement of adenosine A2a receptor in intraocular pressure decrease induced by 2-(1-octyn-1-yl)adenosine or 2-(6-cyano-1-hexyn-1-yl)adenosine.
Topics: Adenosine; Alkynes; Animals; Aqueous Humor; Cyclic AMP; Glaucoma; Humans; Intraocular Pressure; Kinetics; Male; Rabbits; Receptor, Adenosine A2A | 2005 |